MYC and breast cancer: Uploading the list of the identified MYC-regulated genes from the analyzed data set into a survey of the OncomineTM database revealed that the MYC-targeted genes in the data set significantly overlapped with gene sets associated with an exceptionally poor prognosis, including breast cancer clinical outcome i.e. dead at 3 years (Additional file3: Table S2).